Literature DB >> 10827003

Insulin-mediated translocation of GLUT-4-containing vesicles is preserved in denervated muscles.

M Zhou1, G Vallega, K V Kandror, P F Pilch.   

Abstract

Skeletal muscle denervation decreases insulin-sensitive glucose uptake into this tissue as a result of marked GLUT-4 protein downregulation ( approximately 20% of controls). The process of insulin-stimulated glucose transport in muscle requires the movement or translocation of intracellular GLUT-4-rich vesicles to the cell surface, and it is accompanied by the translocation of several additional vesicular cargo proteins. Thus examining GLUT-4 translocation in muscles from denervated animals allows us to determine whether the loss of a major cargo protein, GLUT-4, affects the insulin-dependent behavior of the remaining cargo proteins. We find no difference, control vs. denervated, in the insulin-dependent translocation of the insulin-responsive aminopeptidase (IRAP) and the receptors for transferrin and insulin-like growth factor II/mannose 6-phosphate, proteins that completely (IRAP) or partially co-localize with GLUT-4. We conclude that 1) denervation of skeletal muscle does not block the specific branch of insulin signaling pathway that connects receptor proximal events to intracellular GLUT-4-vesicles, and 2) normal levels of GLUT-4 protein are not necessary for the structural organization and insulin-sensitive translocation of its cognate intracellular compartment. Muscle denervation also causes a twofold increase in GLUT-1. In normal muscle, all GLUT-1 is present at the cell surface, but in denervated muscle a significant fraction (25.1 +/- 6.1%) of this transporter is found in intracellular vesicles that have the same sedimentation coefficient as GLUT-4-containing vesicles but can be separated from the latter by immunoadsorption. These GLUT-1-containing vesicles respond to insulin and translocate to the cell surface. Thus the formation of insulin-sensitive GLUT-1-containing vesicles in denervated muscle may be a compensatory mechanism for the decreased level of GLUT-4.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10827003     DOI: 10.1152/ajpendo.2000.278.6.E1019

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  7 in total

1.  Glut4 storage vesicles without Glut4: transcriptional regulation of insulin-dependent vesicular traffic.

Authors:  Danielle N Gross; Stephen R Farmer; Paul F Pilch
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

2.  Role of insulin-dependent cortical fodrin/spectrin remodeling in glucose transporter 4 translocation in rat adipocytes.

Authors:  Libin Liu; Mark P Jedrychowski; Steven P Gygi; Paul F Pilch
Journal:  Mol Biol Cell       Date:  2006-07-26       Impact factor: 4.138

3.  p115 Interacts with the GLUT4 vesicle protein, IRAP, and plays a critical role in insulin-stimulated GLUT4 translocation.

Authors:  Toshio Hosaka; Cydney C Brooks; Eleonora Presman; Suk-Kyeong Kim; Zidong Zhang; Michael Breen; Danielle N Gross; Elizabeth Sztul; Paul F Pilch
Journal:  Mol Biol Cell       Date:  2005-03-30       Impact factor: 4.138

4.  Glucose transporter content and glucose uptake in skeletal muscle constructs engineered in vitro.

Authors:  Erin L Baker; Robert G Dennis; Lisa M Larkin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Nov-Dec       Impact factor: 2.416

5.  Nur77 coordinately regulates expression of genes linked to glucose metabolism in skeletal muscle.

Authors:  Lily C Chao; Zidong Zhang; Liming Pei; Tsugumichi Saito; Peter Tontonoz; Paul F Pilch
Journal:  Mol Endocrinol       Date:  2007-06-05

Review 6.  Master Regulators of Muscle Atrophy: Role of Costamere Components.

Authors:  Luisa Gorza; Matteo Sorge; Laura Seclì; Mara Brancaccio
Journal:  Cells       Date:  2021-01-03       Impact factor: 6.600

7.  Insulin Resistance Is Not Sustained Following Denervation in Glycolytic Skeletal Muscle.

Authors:  Shawna L McMillin; Erin C Stanley; Luke A Weyrauch; Jeffrey J Brault; Barbara B Kahn; Carol A Witczak
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.